Black Rock Inc. Coherus Bio Sciences, Inc. Put Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CHRS
# of Institutions
121Shares Held
64.4MCall Options Held
96.6KPut Options Held
65.3K-
Vanguard Group Inc Valley Forge, PA11.2MShares$10.1 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY5.26MShares$4.79 Million0.12% of portfolio
-
Tang Capital Management LLC San Diego, CA5.1MShares$4.64 Million0.27% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY3.04MShares$2.76 Million0.11% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.9MShares$2.64 Million0.0% of portfolio
About Coherus BioSciences, Inc.
- Ticker CHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,724,600
- Market Cap $70.7M
- Description
- Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...